| Literature DB >> 10849877 |
Abstract
Applying the results of clinical trials to everyday practice in an appropriate manner can be difficult. Earlier clinical trials focused on the secondary prevention of ventricular arrhythmias. Studying patients at high risk of recurrent ventricular arrhythmias is important, but the overall impact on arrhythmic death is low. Recent arrhythmia trials have studied specific patient populations for the primary prevention of ventricular arrhythmias. New trials will expand the investigation to other populations. This article summarizes the results of large clinical trials in the management of ventricular arrhythmias and attempts to provide guidelines for applying their results to everyday clinical practice.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10849877 DOI: 10.1016/s0733-8651(05)70145-4
Source DB: PubMed Journal: Cardiol Clin ISSN: 0733-8651 Impact factor: 2.213